Status:
COMPLETED
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
Lead Sponsor:
Cancer Trials Ireland
Conditions:
Breast Cancer
Colorectal Cancer
Eligibility:
All Genders
Brief Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in peptides and proteins and identify biomarkers related to cancer...
Detailed Description
OBJECTIVES: Primary * To assess which potential peptide and protein markers produced by human melanoma, lung, breast, pancreatic, and colorectal cell lines may be detectable in serum of patients fro...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of 1 of the following advanced metastatic malignancies:
- Malignant melanoma
- Lung cancer
- Breast cancer
- Pancreatic carcinoma
- Colorectal cancer
- Advanced and/or metastatic disease
- Hormone receptor status not specified
- PATIENT CHARACTERISTICS:
- Menopausal status not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
803 Patients enrolled
Trial Details
Trial ID
NCT00974610
Start Date
August 1 2008
End Date
January 1 2017
Last Update
May 24 2017
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Cork University Hospital
Cork, Ireland
2
Mercy University Hospital
Cork, Ireland
3
Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital
Dublin, Ireland, 24
4
St. Vincent's University Hospital
Dublin, Ireland, 4